| Autor: |
Tauschmann, Martin, Thabit, Hood, Bally, Lia, Allen, Janet M, Hartnell, Sara, Wilinska, Malgorzata E, Ruan, Yue, Sibayan, Judy, Kollman, Craig, Cheng, Peiyao, Beck, Roy W, Acerini, Carlo L, Evans, Mark L, Dunger, David B, Elleri, Daniela, Campbell, Fiona, Bergenstal, Richard M, Criego, Amy, Shah, Viral N, Leelarathna, Lalantha, Hovorka, Roman, Alvarado, B, Ashanti, C, Baggott, J, Balakrishnan, K, Barber, N, Bath, L, Beasley, S, Beatson, C, Borgman, S, Bradshaw, S, Bugielski, B, Carlson, AB, Collett, E, Curtis, J, Demmitt, J, Donahue, D, Exall, J, Forshaw, R, Hayes, J, Heath, S, Hellmann, A, Huegel, V, Hyatt, J, James, L, Joseph, H, Joshee, P, Konerza, W, Lum, J, Madden, M, Martens, T, McCarthy, C, McDonald, M, Mikityuk, V, Miles, H, Miller, D, Mubita, W, Murphy, C, Olson, B, Pad, R, Patibandla, N, Riding, K, Shaju, A, Thomas, LA, Thomson, J, White, D, Yau, S, Yong, J |
| Zdroj: |
The Lancet; October 2018, Vol. 392 Issue: 10155 p1321-1329, 9p |
| Abstrakt: |
The achievement of glycaemic control remains challenging for patients with type 1 diabetes. We assessed the effectiveness of day-and-night hybrid closed-loop insulin delivery compared with sensor-augmented pump therapy in people with suboptimally controlled type 1 diabetes aged 6 years and older. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
